This certification further demonstrates NEB’s commitment to environmental stewardship, scientific advancement and social responsibility as a global life science leader. IPSWICH, MA — New England Biolabs (NEB®), a leader in the discovery and production of enzymes for molecular biology applications, today announced it has become a Certified B Corporation™ (B Corp™), joining a global community […]

This certification further demonstrates NEB’s commitment to environmental stewardship, scientific advancement and social responsibility as a global life science leader. IPSWICH, MA — New England Biolabs (NEB®), a leader in the discovery and production of enzymes for molecular biology applications, today announced it has become a Certified B Corporation™ (B Corp™), joining a global community […]

Achievement Demonstrates OpenEye’s Unparalleled Experience Helping Pharmaceutical and Biotechnology Customers Optimize Computing Workloads SANTA FE, N.M. –  OpenEye Scientific, developer of the world’s only cloud-native molecular design platform, Orion,™ announced today that it is among the first of only a handful of companies globally that have achieved Amazon Web Services (AWS) High Performance Computing (HPC) Competency status. […]

AMSBIO, in association with Nordmark Biochemicals, is now offering animal-free Collagenase and Neutral Protease enzymes, isolated from Clostridium histolyticum, for in vitro tissue dissociation leading to high yields of viable cells. Being animal-free, these enzymes are very safe and offer reduced regulatory hurdles for use in clinical applications. They are manufactured under GMP guidelines using a plant-based production […]

INTEGRA Biosciences, international manufacturer of laboratory equipment with technical and manufacturing centers in Switzerland and the US, officially celebrated the expansion of its state-of-the-art facility in Hudson, NH, with a community ribbon cutting ceremony. The newly extended facilities will expand the company’s US presence to meet the growing demand for its laboratory liquid handling products, which have […]

Achievement Demonstrates OpenEye’s Unparalleled Experience Helping Pharmaceutical and Biotechnology Customers Optimize Computing Workloads SANTA FE, N.M. – OpenEye Scientific, developer of the world’s only cloud-native molecular design platform, Orion,™ announced today that it is among the first of only a handful of companies globally that have achieved Amazon Web Services (AWS) High Performance Computing (HPC) Competency status. […]

Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing CARLSBAD, Calif. — Thermo Fisher Scientific today announced the completion of the U.S. Food and Drug Administration (FDA) listing for the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System. The innovative product enables clinical laboratories and assay developers to meet testing demands and enhance […]

NEW YORK — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced that it has signed a definitive agreement to invest in eMolecules (“eMolecules,” or the “Company”), a novel and fast-growing e-procurement platform for high-value chemicals and bioreagents used by the leading pharmaceutical companies in drug discovery. Financial terms […]

Strong financial performance and the achievement of other key milestones demonstrate the growing strength of Synthace’s offering within the biopharma and biotech industries London, UK: Synthace Ltd, developers of Antha, the cloud-based software platform for automating and improving the success rate of biological processes, today announced it increased its annual recurring revenue by 225% compared […]

In order to contribute to achieving a sustainable society, Shimadzu Corporation (hereafter refered to as “Shimadzu”) has joined the global environmental initiative RE100 and has declared that Shimadzu Group in the world would use 100% renewable energy for its business activities by 2050. As medium-term goals, we are aiming for 85 % renewable electricity by […]